Triple-negative breast cancer (TNBC) is a breast cancer subtype that accounts for approximately 15% of all breast cancers [4] and is characterized by the absence of the expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor 2 receptor (HER2) [5]. The gene discussed is PGR; the disease is breast cancer.